JP2018536446A - 膣用薬剤送達装置および膣診断装置 - Google Patents
膣用薬剤送達装置および膣診断装置 Download PDFInfo
- Publication number
- JP2018536446A JP2018536446A JP2018517822A JP2018517822A JP2018536446A JP 2018536446 A JP2018536446 A JP 2018536446A JP 2018517822 A JP2018517822 A JP 2018517822A JP 2018517822 A JP2018517822 A JP 2018517822A JP 2018536446 A JP2018536446 A JP 2018536446A
- Authority
- JP
- Japan
- Prior art keywords
- vaginal
- flexible
- rigid member
- diagnostic device
- drug delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012377 drug delivery Methods 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 21
- 238000005259 measurement Methods 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 20
- 238000003745 diagnosis Methods 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 20
- 210000001215 vagina Anatomy 0.000 claims description 20
- 238000005452 bending Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 229940088597 hormone Drugs 0.000 claims description 7
- 239000005556 hormone Substances 0.000 claims description 7
- 102000009151 Luteinizing Hormone Human genes 0.000 claims description 6
- 108010073521 Luteinizing Hormone Proteins 0.000 claims description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 6
- 229940040129 luteinizing hormone Drugs 0.000 claims description 6
- -1 polybutylene terephthalate Polymers 0.000 claims description 6
- 229920002379 silicone rubber Polymers 0.000 claims description 6
- 239000013013 elastic material Substances 0.000 claims description 5
- 238000001746 injection moulding Methods 0.000 claims description 5
- 239000004944 Liquid Silicone Rubber Substances 0.000 claims description 4
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 claims description 4
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 claims description 4
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 claims description 4
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 3
- 229960005309 estradiol Drugs 0.000 claims description 3
- 229930182833 estradiol Natural products 0.000 claims description 3
- 239000000186 progesterone Substances 0.000 claims description 3
- 229960003387 progesterone Drugs 0.000 claims description 3
- 229920001634 Copolyester Polymers 0.000 claims description 2
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 claims description 2
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000005062 Polybutadiene Substances 0.000 claims description 2
- 239000004695 Polyether sulfone Substances 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 claims description 2
- 239000000806 elastomer Substances 0.000 claims description 2
- 239000004811 fluoropolymer Substances 0.000 claims description 2
- 229920002313 fluoropolymer Polymers 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920002857 polybutadiene Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920006393 polyether sulfone Polymers 0.000 claims description 2
- 229920002530 polyetherether ketone Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 229920001187 thermosetting polymer Polymers 0.000 claims description 2
- 238000003825 pressing Methods 0.000 abstract description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000016087 ovulation Effects 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000003756 cervix mucus Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 230000002254 contraceptive effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- MXDOOIVQXATHKU-RYVPXURESA-N (8s,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one;(8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical group OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 MXDOOIVQXATHKU-RYVPXURESA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940115044 nuvaring Drugs 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229940044953 vaginal ring Drugs 0.000 description 1
- 239000006213 vaginal ring Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4318—Evaluation of the lower reproductive system
- A61B5/4337—Evaluation of the lower reproductive system of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0012—Ovulation-period determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4318—Evaluation of the lower reproductive system
- A61B5/4325—Evaluation of the lower reproductive system of the uterine cavities, e.g. uterus, fallopian tubes, ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6875—Uterus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/14—Female reproductive, genital organs
- A61M2210/1475—Vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Gynecology & Obstetrics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims (15)
- 膣用薬剤送達装置および/または膣診断装置であって、
第1の端部および第2の端部を有する第1の剛性部材と、
第3の端部および第4の端部を有する第2の剛性部材と、
前記第1の端部と前記第3の端部との間に接続された第1の可撓性部材と、
前記第2の端部と前記第4の端部との間に接続された可撓性部品とを含み、
前記第1の剛性部材および/または第2の剛性部材は、
送達する薬剤を収容する容器、開口、および前記薬剤を前記開口から押出すためのポンプ、および/または
膣内診断またはそのための測定を実施するための診断装置を含み、
前記第1の可撓性部材および前記可撓性部品のうちの少なくとも一方は少なくとも部分的に弾性であり、
前記第1の可撓性部材および前記可撓性部品のうちの少なくとも一方の弾性により、
前記装置をユーザの膣に挿入するために、前記装置を強く押して、伸ばされた形状から押し潰された形状に変形させることができ、
外力がほとんどまたは全く前記装置に加えられていないときに前記装置は予め付勢されて前記伸ばされた形状を有し、前記伸ばされた形状は、実質的に楕円または環状リングの形状に相当し、
前記装置は、ユーザの後部膣円蓋にまたはその近くに配置されて解放されたときに、前記伸ばされた形状に実質的に対応する形状になる、膣用薬剤送達装置および/または膣診断装置。 - 前記装置の外面は実質的に平滑である、請求項1に記載の膣用薬剤送達装置および/または膣診断装置。
- 前記第1の可撓性部材および前記可撓性部品のうちの前記少なくとも一方は、少なくとも部分的に弾性材料からなる、請求項1または2に記載の膣用薬剤送達装置および/または膣診断装置。
- 前記可撓性部品は、
第2の可撓性部材と、
第3の可撓性部材と、
第4の可撓性部材と、
第5の端部および第6の端部を有する第3の剛性部材と、
第7の端部および第8の端部を有する第4の剛性部材とを含み、
前記第2の可撓性部材は、前記第2の端部と前記第5の端部との間に接続され、
前記第3の可撓性部材は、前記第4の端部と前記第7の端部との間に接続され、
前記第4の可撓性部材は、前記第6の端部と前記第8の端部との間に接続される、請求項1〜3のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。 - 前記第2の剛性部材、前記第3の剛性部材、または前記第4の剛性部材は、電気エネルギを前記ポンプおよび/または診断装置に供給するためのバッテリ等の電気エネルギ源を含み、前記装置は、前記エネルギ源と前記ポンプおよび/または診断装置との間の第1の可撓性電気接続をさらに含み、前記第1の可撓性電気接続は、前記ポンプおよび/または診断装置と前記電気エネルギ源を保持する前記剛性部材との間に配置された前記可撓性部材に収容される、請求項1〜4のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記ポンプおよび前記エネルギ源は、前記第1の剛性部材、前記第2の剛性部材、前記第3の剛性部材、および前記第4の剛性部材のうちの異なる剛性部材にそれぞれ収容され、および/または
前記診断装置および前記エネルギ源は、前記第1の剛性部材、前記第2の剛性部材、前記第3の剛性部材、および前記第4の剛性部材のうちの異なる剛性部材にそれぞれ収容される、請求項5に記載の膣用薬剤送達装置および/または膣診断装置。 - 前記第1の剛性部材、前記第2の剛性部材、前記第3の剛性部材、または前記第4の剛性部材は、前記ポンプおよび/または診断装置を制御するためのコントローラを含む、請求項1〜6のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記診断装置は、エストラジオール、黄体形成ホルモン(LH)、およびプロゲステロンのようなホルモンのレベル、またはブドウ糖等の、生化学化合物および/または薬剤、および/またはその他の生化学パラメータおよび/または投薬レベルを測定するためのセンサを含み、
前記第1の剛性部材、前記第2の剛性部材、前記第3の剛性部材、および前記第4の剛性部材はこのようなセンサを含み、前記コントローラは前記センサにより実施された測定に応じて前記ポンプを制御するように構成されている、請求項1〜7のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。 - 前記装置は、前記センサと前記コントローラとの間の第2の可撓性電気接続、および/または前記エネルギ源と前記コントローラとの間の第3の可撓性電気接続、および/または前記コントローラと前記ポンプおよび/または診断装置との間の第4の可撓性電気接続をさらに含み、前記第2の可撓性電気接続、前記第3の可撓性電気接続、および/または前記第4の可撓性電気接続は、少なくとも部分的に、前記第1、第2、第3、および/または第4の可撓性部材に収容される、請求項5〜8のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記第1、第2、第3、および/または第4の剛性部材、ならびに前記第1、第2、第3、および/または第4の可撓性部材は、好ましくは射出成形により、それぞれの材料組成物を用いて形成され、前記剛性部材に使用される前記材料組成物は、前記可撓性部材に使用される前記材料組成物と異なり、
前記可撓性部材と前記剛性部材との間の接続は好ましくは固定され、好ましくは前記可撓性および/または剛性部材の射出成形中に形成され、および/または
前記剛性部材のうちの少なくとも1つに使用される前記材料組成物は、好ましくは、ポリオレフィン、ABS(アクリロニトリルブタジエンスチレン)、PA(ポリアミド)、PBTコポリエステル(ポリブチレンテレフタレート)、ポリエチレン、ポリプロピレン、ポリスチレン、ポリエステル、ポリエステル(PLAおよびその他の生体吸収性プラスチック)、ポリカーボネート、ポリ塩化ビニル、ポリエーテルスルホン、ポリスルホン、およびポリエーテルエーテルケトンからなる群の材料のうちの1つ以上を含み、および/または
前記可撓性部材のうちの少なくとも1つに使用される前記材料組成物は、好ましくは、LSR(液状シリコーンゴム)、熱可塑性エラストマー(TPE、TPU)、シリコーンゴム、ブタジエンゴム、フッ素重合体等の熱硬化性エラストマー、ポリ(p−キシレン)(パリレン)、およびポリメタクリル酸メチル(PMMA)等のポリアクリレートからなる群の材料のうちの1つ以上を含む、請求項1〜9のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。 - 前記装置は前記伸ばされた形状で中心軸方向軸の周りに延在し、
前記軸方向軸に垂直な面において求めた前記装置の外径は、50〜70mmの範囲、より好ましくは55〜65mmの範囲に含まれ、
前記軸方向軸に平行な断面において求めた前記装置の内側径は、4〜8mmの範囲に含まれ、
前記装置は好ましくは外径が実質的に一定であるリング形状を有し、および/または前記軸方向軸に垂直な面において求めた前記装置の内径は、好ましくは前記剛性部材のうちの少なくとも1つの近くにおいて小さくなっている、請求項1〜10のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。 - 前記剛性部材のうちの少なくとも1つは、分離された状態において、0.5Nの力が加力ポイントに加えられたときに曲げ角度が10度を超えない曲げ強度を有し、前記加力ポイントは、前記剛性部材が保持され固定されている固定ポイントから20mmの距離にあり、前記曲げ角度は、前記力を加えたために生じる前記固定ポイントと前記加力ポイントとの間に延在するラインの前記固定ポイントを中心とする回転に関連する回転角度に相当する、請求項1〜11のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記可撓性部材のうちの少なくとも1つは、分離された状態において、0.5Nの力が加力ポイントに加えられたときに曲げ角度が30度を超える曲げ強度を有し、前記加力ポイントは、前記剛性部材が保持され固定されている固定ポイントから20mmの距離にあり、前記曲げ角度は、前記力を加えたために生じる前記固定ポイントと前記加力ポイントとの間に延在するラインの前記固定ポイントを中心とする回転に関連する回転角度に相当する、請求項1〜12のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記センサによって実施された測定に対応する測定データおよび/または前記診断装置によって出力された測定データまたは診断情報を無線送信するように構成された送信機をさらに含む、請求項1〜13のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
- 前記ポンプ、前記センサ、および前記診断装置のうちの少なくとも1つを遠隔制御するための制御コマンドを無線受信するための受信機をさらに含み、前記受信機および送信機は組合されて1つのトランシーバユニットを構成し得る、請求項1〜14のいずれかに記載の膣用薬剤送達装置および/または膣診断装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15188465.7 | 2015-10-06 | ||
EP15188465.7A EP3153137A1 (en) | 2015-10-06 | 2015-10-06 | Vaginal drug delivery device and vaginal diagnostic device |
PCT/EP2016/073788 WO2017060299A1 (en) | 2015-10-06 | 2016-10-05 | Vaginal drug delivery device and vaginal diagnostic device |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018536446A true JP2018536446A (ja) | 2018-12-13 |
JP7159045B2 JP7159045B2 (ja) | 2022-10-24 |
Family
ID=54260676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018517822A Active JP7159045B2 (ja) | 2015-10-06 | 2016-10-05 | 膣用薬剤送達装置および膣診断装置 |
Country Status (6)
Country | Link |
---|---|
US (1) | US12036033B2 (ja) |
EP (2) | EP3153137A1 (ja) |
JP (1) | JP7159045B2 (ja) |
CN (1) | CN108135731B (ja) |
ES (1) | ES2793352T3 (ja) |
WO (1) | WO2017060299A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2568672B (en) | 2017-11-17 | 2021-08-04 | Samsung Electronics Co Ltd | Improvements in and relating to BWP setup and signalling in a telecommunication system |
EP3773542A1 (en) * | 2018-04-10 | 2021-02-17 | Li Galli B.V. | Vaginal systemic drug delivery |
US20210113120A1 (en) * | 2018-04-10 | 2021-04-22 | Ligalli B.V. | Vaginal Measurements Using a Vaginal Ring |
CN116963730A (zh) | 2021-02-28 | 2023-10-27 | 里加利私人有限公司 | 借助于阴道环利用施用的奥昔布宁治疗膀胱过度活动症 |
WO2023062181A1 (en) | 2021-10-14 | 2023-04-20 | Ligalli B.V. | Tumor markers |
NL2032800B1 (en) | 2022-08-18 | 2024-02-27 | Ligalli B V | Vaginal ring device with Bluetooth connectivity |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5928195A (en) * | 1996-01-31 | 1999-07-27 | Malamud; Daniel | Remote control drug delivery device |
US20060084848A1 (en) * | 2004-10-14 | 2006-04-20 | Mark Mitchnick | Apparatus and methods for monitoring subjects |
US20130192606A1 (en) * | 2010-10-13 | 2013-08-01 | Con TIP Ltd. | Apparatuses and methods of intravaginal support and/or distension |
WO2014135521A1 (en) * | 2013-03-08 | 2014-09-12 | Li Galli B.V. | Vaginal drug delivery and/or diagnostic system |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2574767A (en) * | 1950-04-14 | 1951-11-13 | Stubbs George | Pessary |
US6158435A (en) * | 1998-09-14 | 2000-12-12 | Dorsey; Denis P. | Pessary |
US8765031B2 (en) | 2009-08-13 | 2014-07-01 | Align Technology, Inc. | Method of forming a dental appliance |
US20130066302A1 (en) * | 2009-09-29 | 2013-03-14 | MEDIMETRICS Personalized Drug Delivery B.V. | Intrauterine electronic capsule for administering a substance |
US8715204B2 (en) * | 2010-07-14 | 2014-05-06 | Prima Temp, Inc. | Wireless vaginal sensor probe |
US9610398B2 (en) * | 2011-11-22 | 2017-04-04 | Incube Labs, Llc | Implantable solid-liquid drug delivery apparatus, formulations, and methods of use |
WO2014090976A1 (en) | 2012-12-14 | 2014-06-19 | Laboratoire Hra-Pharma | Copper intrauterine device |
CN106573015B (zh) * | 2014-06-11 | 2021-11-26 | 麻省理工学院 | 肠溶弹性体 |
US10939865B2 (en) * | 2015-10-06 | 2021-03-09 | Ligalli B.V. | Vaginal drug delivery device and vaginal diagnostic device |
-
2015
- 2015-10-06 EP EP15188465.7A patent/EP3153137A1/en not_active Withdrawn
-
2016
- 2016-10-05 EP EP16781335.1A patent/EP3359099B1/en active Active
- 2016-10-05 ES ES16781335T patent/ES2793352T3/es active Active
- 2016-10-05 JP JP2018517822A patent/JP7159045B2/ja active Active
- 2016-10-05 CN CN201680057947.3A patent/CN108135731B/zh active Active
- 2016-10-05 WO PCT/EP2016/073788 patent/WO2017060299A1/en active Application Filing
-
2021
- 2021-01-22 US US17/155,651 patent/US12036033B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5928195A (en) * | 1996-01-31 | 1999-07-27 | Malamud; Daniel | Remote control drug delivery device |
US20060084848A1 (en) * | 2004-10-14 | 2006-04-20 | Mark Mitchnick | Apparatus and methods for monitoring subjects |
US20130192606A1 (en) * | 2010-10-13 | 2013-08-01 | Con TIP Ltd. | Apparatuses and methods of intravaginal support and/or distension |
WO2014135521A1 (en) * | 2013-03-08 | 2014-09-12 | Li Galli B.V. | Vaginal drug delivery and/or diagnostic system |
Also Published As
Publication number | Publication date |
---|---|
US12036033B2 (en) | 2024-07-16 |
EP3359099A1 (en) | 2018-08-15 |
WO2017060299A1 (en) | 2017-04-13 |
EP3153137A1 (en) | 2017-04-12 |
CN108135731A (zh) | 2018-06-08 |
ES2793352T3 (es) | 2020-11-13 |
EP3359099B1 (en) | 2020-03-11 |
JP7159045B2 (ja) | 2022-10-24 |
CN108135731B (zh) | 2021-07-23 |
US20210137444A1 (en) | 2021-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12036033B2 (en) | Vaginal drug delivery device and vaginal diagnostic device | |
CN110022949B (zh) | 用于训练骨盆底肌肉的装置、系统、和方法 | |
EP2964088B1 (en) | Vaginal drug delivery and/or diagnostic system | |
KR102179601B1 (ko) | 약물 전달과 관련된 정보를 전달하기 위한 전기 정보 장치 | |
JP2019528103A5 (ja) | ||
US20180271752A1 (en) | Drug delivery capsules with external intelligence | |
US10792424B2 (en) | Liquid medicine administration device | |
US9220656B2 (en) | Method and aparatus for artificial insemination | |
US20130211372A1 (en) | Body Cavity Physiological Measurement Device | |
KR101592154B1 (ko) | 음경 발기력 측정장치 | |
KR20180059903A (ko) | 진동 센서를 구비한 약물 전달 장치 | |
US10939865B2 (en) | Vaginal drug delivery device and vaginal diagnostic device | |
CN107405299A (zh) | 阴道药物递送装置 | |
WO2017035335A1 (en) | Vaginal applicator for pharmaceutical preparations | |
CN113543751A (zh) | 用于插入和移除iud的装置、系统、方法和套件 | |
US20240299209A1 (en) | Vaginal Therapeutic Delivery Device | |
US20240342449A1 (en) | Systems and Devices for Facilitating Conception | |
GB2558573A (en) | Improvements in or relating to a medicament dispenser | |
WO2023212785A1 (en) | Stimulation system | |
EA045214B1 (ru) | Внутриматочная система с замковой частью |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190906 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200825 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210323 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210621 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210820 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220422 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220614 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220719 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220913 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221012 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7159045 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |